NIH-funded research NIH-funded research

Affordable, simple cervical cancer screening and diagnosis tools for women with HIV in LMICs and the US

Official title: The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV

Funded at University of Tx Md Anderson Can Ctr · NIH-11535315 · Data updated 2026-11-12

A collaboration to create affordable, easy-to-use cervical cancer screening and diagnostic tools for women living with HIV, especially in low-resource settings.

More Cervical Cancer research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Tx Md Anderson Can Ctr
NIH-funded
Lab location1 site (Houston, United States)
Project startAugust 1, 2023
Project endJuly 31, 2028
Funding year2026
Award (this year)$120,096
NIH project number3U54CA277843-04S3
Project IDNIH-11535315 on NIH RePORTER

Who could benefit from this research

Could help

Women living with HIV who are at risk for cervical cancer, particularly in LMIC settings, and populations in the US seeking improved screening options.

Less likely to help

Patients without access to HIV care or cervical cancer screening programs may not directly benefit from this project.

What this research studies

This project brings together teams in the United States, Mozambique, and Brazil to develop low-cost technologies that can screen, diagnose, and treat cervical cancer in women with HIV. It focuses on making prevention and early detection accessible where resources are limited, with practical tools that can be deployed in real-world clinics. The effort combines engineering, pathology, epidemiology, and behavioral science to move from idea to usable solutions that fit patient needs and local healthcare systems. If successful, these innovations could reduce the burden of cervical cancer in vulnerable populations and improve outcomes for people living with HIV.

Why it matters

Potential benefit: It could lead to affordable, accessible screening and diagnostic options that catch cervical cancer earlier and improve survival for women with HIV.

How similar studies have gone: Previous studies show that low-cost screening approaches can work in LMICs, but this project aims to advance practical, deployable options suitable for varied healthcare settings.

Where this research is happening

  • University of Tx Md Anderson Can Ctr
    Houston, United States
    Active

Researchers

  • Principal investigator: Schmeler, Kathleen — University of Tx Md Anderson Can Ctr
  • Study coordinator: Schmeler, Kathleen

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.